Detalhe da pesquisa
1.
Expression of the novel tumour suppressor sterile alpha motif and HD domain-containing protein 1 is an independent adverse prognostic factor in classical Hodgkin lymphoma.
Br J Haematol
; 193(3): 488-496, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33528031
2.
PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program.
Mod Pathol
; 32(6): 741-754, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30666052
3.
Down-regulation of the cyclin-dependent kinase inhibitor p57 is mediated by Jab1/Csn5 in hepatocarcinogenesis.
Hepatology
; 63(3): 898-913, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26606000
4.
Trametinib and Dabrafenib in histiocytic sarcoma transdifferentiated from chronic lymphocytic leukemia with a K-RAS and a unique BRAF mutation.
Ann Hematol
; 99(3): 649-651, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32009180
5.
Expression of Somatostatin Receptors 1-5 and Dopamine Receptor 2 in Lung Carcinoids: Implications for a Therapeutic Role.
Neuroendocrinology
; 101(3): 211-22, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25765100
6.
The oncogenic JUNB/CD30 axis contributes to cell cycle deregulation in ALK+ anaplastic large cell lymphoma.
Br J Haematol
; 167(4): 514-23, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25145835
7.
CD274 (PD-L1)/PDCD1 (PD-1) expression in de novo and transformed diffuse large B-cell lymphoma.
Br J Haematol
; 180(5): 744-748, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27879989
8.
Interruption of p53-MDM2 Interaction by Nutlin-3a in Human Lymphoma Cell Models Initiates a Cell-Dependent Global Effect on Transcriptome and Proteome Level.
Cancers (Basel)
; 15(15)2023 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37568720
9.
Establishment and characterization of a novel breast implant-associated anaplastic large cell lymphoma cell line and PDX model (BIA-XR1) with a unique KRAS mutation.
Curr Res Transl Med
; 71(3): 103401, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37364351
10.
Expression patterns of endothelin-1 and its receptors in colorectal cancer.
J Surg Oncol
; 105(7): 643-9, 2012 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22213082
11.
ALK+ Anaplastic Large Cell Lymphoma (ALCL)-Derived Exosomes Carry ALK Signaling Proteins and Interact with Tumor Microenvironment.
Cancers (Basel)
; 14(12)2022 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35740600
12.
Sting Is Commonly and Differentially Expressed in T- and Nk-Cell but Not B-Cell Non-Hodgkin Lymphomas.
Cancers (Basel)
; 14(5)2022 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35267494
13.
The proteomic signature of NPM/ALK reveals deregulation of multiple cellular pathways.
Blood
; 114(8): 1585-95, 2009 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-19531656
14.
MDMX/MDM4 is highly expressed and contributes to cell growth and survival in anaplastic large cell lymphoma.
Leuk Lymphoma
; 62(7): 1563-1573, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33569988
15.
mTOR signaling is activated by FLT3 kinase and promotes survival of FLT3-mutated acute myeloid leukemia cells.
Mol Cancer
; 9: 292, 2010 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21067588
16.
Programmed death-ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21-gene and 70-gene signatures in estrogen receptor-positive disease.
Mol Oncol
; 14(5): 951-963, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32115850
17.
AP-1 Transcription Factors as Regulators of Immune Responses in Cancer.
Cancers (Basel)
; 11(7)2019 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31340499
18.
STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer.
Cancers (Basel)
; 11(10)2019 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31581535
19.
Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL.
Cancer Immunol Res
; 7(4): 644-657, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30745366
20.
Mammalian target of rapamycin (mTOR) pathway signalling in lymphomas.
Expert Rev Mol Med
; 10: e4, 2008 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-18241520